Financial, market and economic news

Gland Pharma’s grey market premium soars ahead of Friday’s debut

The retail and HNI portion of the IPO were subscribed just 51 per cent and 24 per cent, respectively

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy